Tuesday, 18 February 2020
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
JHOP Print Edition
We will request your mailing address on the next page.
JHOP/TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
JHOP
's
Privacy Policy
, and
JHOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date
Home
Issues
2019
December 2019 Vol 9, No 4
September 2019 Vol 9, No 3
June 2019 Vol 9, No 2
March 2019 Vol 9, No 1
2018
December 2018 Vol 8, No 4
September 2018 Vol 8, No 3
June 2018 Vol 8, No 2
March 2018 Vol 8, No 1
2017
December 2017 Vol 7, No 4
September 2017 Vol 7, No 3
June 2017 Vol 7, No 2
March 2017 Vol 7, No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Kirollos S. Hanna, PharmD, BCPS, BCOP
Hematology/Oncology Clinical Pharmacist
Mayo Clinic Hospital
Methodist Campus
Rochester, MN
Authored Items
Comparing Granulocyte Colony-Stimulating Factors Prescribing Practices versus Guideline Recommendations in a Large Community Cancer Center
Kirollos S. Hanna, PharmD, BCPS, BCOP
,
Robert Mancini, PharmD, BCOP
,
Dave Wilson, PharmD
,
Dan Zuckerman, MD
JHOP - September 2019 Vol 9, No 3
in
Practical Issues for Pharmacists
Review of PD-1–Induced Myositis and a Case of Pembrolizumab-Induced Myositis in a Patient with Metastatic Melanoma
Kirollos S. Hanna, PharmD, BCPS, BCOP
JHOP - December 2018 Vol 8, No 4
in
Review Article
Aplastic Anemia in a Patient with Anaplastic Oligodendroglioma Postradiation and Concurrent Temozolomide Therapy: Case Report and Review of the Literature
Kirollos S. Hanna, PharmD, BCPS, BCOP
,
Robert Mancini, PharmD, BCOP
,
Matthew Burtelow, MD, PhD
,
Benjamin Bridges, MD
JHOP - March 2018 Vol 8, No 1
in
Case Reports
Last modified: April 12, 2018
Home
Issues
2019
December 2019 Vol 9, No 4
September 2019 Vol 9, No 3
June 2019 Vol 9, No 2
March 2019 Vol 9, No 1
2018
December 2018 Vol 8, No 4
September 2018 Vol 8, No 3
June 2018 Vol 8, No 2
March 2018 Vol 8, No 1
2017
December 2017 Vol 7, No 4
September 2017 Vol 7, No 3
June 2017 Vol 7, No 2
March 2017 Vol 7, No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
